Pathological Uterine Perfusion in the Second Trimester Is Not Associated with Neutrophil Activation

Hypertension in Pregnancy

Volumn 22, Issue 3, 2003, Pages 239-245

  Stepan, Holger ^a,b   Heihoff Klose, Anne ^a   Faber, Renaldo ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Department of Obstetrics ^*  (Germany)

Author keywords

Intrauterine growth retardation; Myeloperoxidase; PMN elastase; Preeclampsia; Uterine perfusion

Indexed keywords

ELASTASE; MYELOPEROXIDASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; PATHOPHYSIOLOGY; PREECLAMPSIA; SECOND TRIMESTER PREGNANCY; UTERUS BLOOD FLOW;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; LEUKOCYTE ELASTASE; NEUTROPHIL ACTIVATION; PEROXIDASE; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; UTERUS;

EID: 0142057290     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-120024027     Document Type: Article

References (23)

1. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179(5):1359-1375.
2. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180(2):499-506.
3. van Wijk MJ, Kublickiene K, Boer K, van Bavel E. Vascular function in preeclampsia. Cardiovasc Res 2000; 47(1):38-48.
4. Dietl J. The pathogenesis of pre-eclampsia: new aspects. J Perinat Med 2000; 28(8): 464-471.
5. Clark P, Boswell F, Greer IA. The neutrophil and preeclampsia. Semin Reprod Endocrinol 1998; 16(1):57-64.
6. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102(1):20-25.
7. Stallmach T, Hebisch G, Joller-Jemelka HI, Orban P, Schwaller J, Engelmann M. Cytokine production and visualized effects in the feto-placental unit: quantitative and topographic data on cytokines during intrauterine disease. Lab Invest 1995; 73(3):384-392.
8. Barnett CC, Moore EE, Moore FA, Biffle WL, Patrick DA. Soluble intracellular adhesion molecule-1 provokes polymorphonuclear leukocyte elastase release by CD 18. Surgery 1996; 120(2):395-402.
9. Ruchaud-Sparagano MH, Drost EM, Donnelly SC, Bird MI, Haslett C, Dransfield I. Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol 1998; 28(1):80-89.
10. Heyl W, Handt S, Reister F, Gehlen J, Mittermayer C, Rath W. The role of soluble adhesion molecules in evaluating endothelial activation in preeclampsia. Am J Obstet Gynecol 1999; 180(1):68-72.
11. Sabatier F, Bretelle F, d'Ercole C, Boubli L, Sampol J, Dignat-George F. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction. Am J Obstet Gynecol 2000; 183(6):1558-1563.
12. Hammer A, Desoye G, Dohr G, Sattler W, Malle E. Myeloperoxidase-dependent generation of hypochloride-modified proteins in human placental tissues during normal pregnancy. Lab Invest 2001; 81(4):543-554.
13. Mellembakken JR, Hogasen K, Mollnes TE, Hack CE, Abyholm T, Videm V. Increased systemic activation of neutrophils but not complement in preeclampsia. Obstet Gynecol 2001; 97(3):371-374.
14. Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1992; 79(1):19-26.
15. Butterworth BH, Greer IA, Liston WA, Haddad NG, Johnston TA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol 1991; 98(9): 929-933.
16. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158(4):892-898.
17. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones S, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187:127-136.
18. Campbell S, Pearce JM, Hackett G, Cohen-Overbeck T, Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol 1986; 68(5):649-653.
19. Chien PF, Arnott N, Gordon A, Owen P, Khan KS. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. Br J Obstet Gynaecol 2000; 107(2): 196-208.
20. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18(5): 441-449.
21. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000; 96(4):559-564.
22. Faas MM, Schuiling GA. Pre-eclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol 2001; 95(2):213-217.
23. Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993; 143(2):473-479.